{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:04:04Z","timestamp":1773299044388,"version":"3.50.1"},"reference-count":59,"publisher":"Informa Healthcare","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2007,3,1]]},"DOI":"10.1185\/030079906x167615","type":"journal-article","created":{"date-parts":[[2007,2,12]],"date-time":"2007-02-12T23:43:18Z","timestamp":1171323798000},"page":"585-594","source":"Crossref","is-referenced-by-count":53,"title":["A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis"],"prefix":"10.1185","volume":"23","author":[{"given":"Deborah T.","family":"Gold","sequence":"first","affiliation":[{"name":"Duke University Medical Center, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley C.","family":"Martin","sequence":"additional","affiliation":[{"name":"University of Arkansas for Medical Sciences, Little Rock, AR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Frytak","sequence":"additional","affiliation":[{"name":"i3 Innovus, Eden Prairie, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayur M.","family":"Amonkar","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"Cosman","sequence":"additional","affiliation":[{"name":"Helen Hayes Hospital, West Haverstraw, NY, and Columbia University Medical Center, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2007,2,9]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(02)00061-0"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.78.923.526"},{"key":"CIT0003","unstructured":"US Congress OoTA. Hip fracture outcomes in people aged fifty and over [online]. Available from http:\/\/www.wws.princeton.%20edu\/cgi-bin\/byteserv.prl\/~ota\/disk1\/1994\/9413\/9413.PDF [May 10, 2005]"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-6-817"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)09075-8"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.11.1215"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.4.721"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.3.320"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200053"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)90023-1"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2002.054"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.12968\/hosp.2004.65.9.15983"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040325"},{"key":"CIT0014","first-page":"309","volume":"104","author":"Rozkydal Z","year":"2003","journal-title":"Bratisl Lek Listy"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1007\/BF03324509"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031975"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200087"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.83B3.0830316"},{"key":"CIT0019","first-page":"101","volume":"29","author":"Cole RP","year":"1999","journal-title":"Haboubi A. Osteoporosis management: physicians\u2019 recommendations and womens\u2019 compliance following osteoporosis testing. Women Health"},{"key":"CIT0020","first-page":"6","volume":"6","author":"Emkey R","year":"2004","journal-title":"Med Gen Med"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511303332201"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440430099012"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540380073035"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.24.2077"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.14.1344"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050010"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102013440503"},{"key":"CIT0028","first-page":"711","volume":"37","author":"Eichner SF","year":"2003","journal-title":"Comparing therapies for postmenopausal osteoporosis prevention and treatment. Ann Pharmacother"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(03)00362-0"},{"key":"CIT0030","first-page":"859","volume":"5","author":"Segal E","year":"2003","journal-title":"Compliance of osteoporotic patients with different treatment regimens. Isr Med Assoc J"},{"key":"CIT0031","first-page":"259","volume":"14","author":"Hamilton B","year":"2003","journal-title":"Tolerability and compliance with risedronate in clinical practice. Osteoporosis Int"},{"key":"CIT0032","first-page":"271","volume":"48","author":"McCombs JS","year":"2004","journal-title":"Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X61875"},{"key":"CIT0034","first-page":"21","volume":"31","author":"Sunyecz J","year":"2006","journal-title":"Persistence with medication in women taking daily versus weekly bisphosphonates for osteoporosis. The Female Patient"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0085-2"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.4065\/81.8.1013"},{"key":"CIT0037","first-page":"856","volume":"80","author":"Recker RR","year":"2005","journal-title":"Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc"},{"key":"CIT0038","first-page":"S107","volume":"15","author":"Sebaldt RJ","year":"2004","journal-title":"Osteoporosis Int"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1502-4"},{"key":"CIT0040","unstructured":"Finigan J, Bainbridge P, Eastell R. Adherence to osteoporosis therapies. Osteoporosis Int 2001;12:[abstract P.110]"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1652-z"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.4065\/81.8.1013"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2004.10.2.142"},{"key":"CIT0044","first-page":"S407","volume":"16","author":"Watts NB","year":"2001","journal-title":"J Bone Miner Res"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-003-0042-4"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1097\/00042192-199822010-00002"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199812010-00002"},{"key":"CIT0048","unstructured":"Prestwood KM. Osteoporosis: up-to-date strategies for prevention and treatment [Interview by Marc E. Weksler]. Geriatrics 1997;52:92\u20134, 7\u20138"},{"key":"CIT0049","first-page":"109","volume":"12","author":"Gallagher JC","year":"1992","journal-title":"Semin Nephrol"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1597-2"},{"key":"CIT0051","first-page":"490","volume":"14","author":"Liel Y","year":"2003","journal-title":"Impact of subsidizing effective anti-osteoporosis drugs on compliance with management guidelines in patients following low-impact fractures. Osteoporosis Int"},{"key":"CIT0052","first-page":"1117","volume":"89","author":"Clowes JA","year":"2004","journal-title":"Eastell R. The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab"},{"key":"CIT0053","first-page":"1296","volume":"23","author":"Claxton AJ","year":"2001","journal-title":"A systematic review of the associations between dose regimens and medication compliance. Clin Ther"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80085-6"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X74862"},{"key":"CIT0056","first-page":"522","volume":"12","author":"Ettinger MP","year":"2006","journal-title":"Medication persistence with weekly versus daily doses of orally administered bisphosphonates. Endocr Pract"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00268-5"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-198808000-00007"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(99)80026-5"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X167615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T13:36:17Z","timestamp":1599312977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X167615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3,1]]}},"alternative-id":["10.1185\/030079906X167615"],"URL":"https:\/\/doi.org\/10.1185\/030079906x167615","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,9]]}}}